TITLE:
Bone Mineral Density (BMD) in Adolescents With Growth Hormone Deficiency (GHD)

CONDITION:
Dwarfism, Pituitary

INTERVENTION:
NONE

SUMMARY:

      This study is a multicenter, open-label, postmarketing surveillance study. The substudy will
      collect information on BMD in adolescents and young adults with GHD or Turner syndrome who
      are completing GH treatment for statural indications.
    

DETAILED DESCRIPTION:
NONE

ELIGIBILITY:
Gender: All
Age: N/A to 17 Years
Criteria:

        Inclusion Criteria:

          -  Bone age of at least 15 years for girls or at least 16 years for boys within 6 months
             of obtaining the DXA scan

          -  Previous enrollment in the NCGS core study, 85-036

          -  Tanner Stage 4 or greater

          -  Either spontaneous or induced puberty

          -  Subjects who plan on terminating GH treatment for statural purposes for one or more
             of the following reasons: epiphyseal fusion, slowing growth rate indicates that near
             adult height has been reached, or satisfied with current height

        Exclusion Criteria:

          -  Current therapy with a non Genentech GH product

          -  Pregnancy (to avoid exposure to low levels of radiation from DXA scanners)

          -  Bilateral hip replacement

          -  Weight >130 kg (286 lb.)
      
